Science and Research

BEAR-STUDY: A Randomised, Placebo-Controlled, 3-Arm, Double-Blind, Multicentre, Phase 4 Study to Assess the Efficacy of OM-85 (Broncho-Vaxom) Short- and Long-Term Treatment vs. Placebo in the Prevention of Respiratory Tract Infections in Children Aged Between 6 Months and 5 Years with Wheezing Lower Respiratory Illness

This study will assess the efficacy and safety of OM-85 compared to placebo in reducing the number of respiratory tract infections (RTIs) in children aged between 6 months and 5 years.
Detailed Description

Study details
Study-ID: NCT05677763, 2022-000886-42
Study-ID: NCT05677763, 2022-000886-42
DZL Disease Area: AA, CFBE
DZL Disease Area: AA, CFBE
Study Type: Interventional
Study Type: Interventional
DZL Role: DZL recruiting center, DZL discovery-based
DZL Role: DZL recruiting center, DZL discovery-based
Funding: Externally - industry
Funding: Externally - industry
DZL Participating Sites: ARCN, BREATH, CPC-M, UGMLC
DZL Participating Sites: ARCN, BREATH, CPC-M, UGMLC
Start Date: 03.05.2023
Completion Date: 30.09.2026
Status: Active / not recruiting
Status: Active / not recruiting
DZL recruiting center, DZL discovery-based
Link to Study


chevron-down